News
There is an unmet need for safe, effective, long-term therapies for autoimmune disorders. NIH inventors have isolated a population of mammalian cells comprising about 75% or higher B-1a regulatory cells (Bregs) and methods of preparation of such cell populations as a therapeutic for immune-related
Join AUTM for the Essentials of Academic Technology Transfer Virtual Course . Attendees will receive a deeper understanding of the fundamental goals and processes of technology transfer. The course walks through the basic skills and resources needed to evaluate inventions and negotiate license
Louis Staudt, M.D., Ph.D. was recently awarded the Career Achievement Award, which recognizes ten or more years in HHS and dedication and loyalty to the Department. Dr. Staudt is the Chief of the Lymphoid Malignancies Branch at NCI. Dr. Staudt pioneered the use of gene expression profiling to
Register for your spot at the National Cancer Institute (NCI) and Frederick National Lab (FNL) 2021 Technology Showcase. This event provides potential partners the opportunity to attend presentations on federal technologies ready for commercialization and/or collaboration, watch panel sessions